Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-003819
Filing Date
2014-08-14
Accepted
2014-08-14 17:22:34
Documents
13
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kite-10q_20140630.htm 10-Q 1382491
2 EX-3.1 kite-ex31_20140630616.htm EX-3.1 35832
3 EX-3.2 kite-ex32_20140630615.htm EX-3.2 157975
4 EX-31.1 kite-ex31_2014063012.htm EX-31 8930
5 EX-31.2 kite-ex31_2014063013.htm EX-31 8921
6 EX-32.1 kite-ex32_2014063014.htm EX-32 6789
7 EX-32.2 kite-ex32_2014063015.htm EX-32 6257
  Complete submission text file 0001564590-14-003819.txt   7744356

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT kite-20140630.xml EX-101.INS 1083907
9 XBRL TAXONOMY EXTENSION SCHEMA kite-20140630.xsd EX-101.SCH 49402
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kite-20140630_cal.xml EX-101.CAL 34319
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kite-20140630_def.xml EX-101.DEF 306642
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE kite-20140630_lab.xml EX-101.LAB 412002
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kite-20140630_pre.xml EX-101.PRE 354399
Mailing Address 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address 2225 COLORADO AVENUE SANTA MONICA CA 90404 (310) 824-9999
Kite Pharma, Inc. (Filer) CIK: 0001510580 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-36508 | Film No.: 141044338
SIC: 2836 Biological Products, (No Diagnostic Substances)